Statistics
Publications
1
Citations
104
H-Index
1
Active since
2025
Affiliations
Duke University(Current)
Bushangqing Liu is an author at Duke University specializing in her2-positive breast cancer immunotherapy, immunogenic cell death induction, and human epidermal growth factor receptor 2-targeted therapy.
Publications per year
2025–2025
1
1